Correlation Between Mineralys Therapeutics, and Bright Minds

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Bright Minds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Bright Minds into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Bright Minds Biosciences, you can compare the effects of market volatilities on Mineralys Therapeutics, and Bright Minds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Bright Minds. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Bright Minds.

Diversification Opportunities for Mineralys Therapeutics, and Bright Minds

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Mineralys and Bright is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Bright Minds Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bright Minds Biosciences and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Bright Minds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bright Minds Biosciences has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Bright Minds go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Bright Minds

Given the investment horizon of 90 days Mineralys Therapeutics, is expected to generate 86.52 times less return on investment than Bright Minds. But when comparing it to its historical volatility, Mineralys Therapeutics, Common is 22.13 times less risky than Bright Minds. It trades about 0.03 of its potential returns per unit of risk. Bright Minds Biosciences is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  126.00  in Bright Minds Biosciences on August 26, 2024 and sell it today you would earn a total of  3,407  from holding Bright Minds Biosciences or generate 2703.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Mineralys Therapeutics, Common  vs.  Bright Minds Biosciences

 Performance 
       Timeline  
Mineralys Therapeutics, 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Mineralys Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Bright Minds Biosciences 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bright Minds Biosciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Bright Minds reported solid returns over the last few months and may actually be approaching a breakup point.

Mineralys Therapeutics, and Bright Minds Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mineralys Therapeutics, and Bright Minds

The main advantage of trading using opposite Mineralys Therapeutics, and Bright Minds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Bright Minds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Minds will offset losses from the drop in Bright Minds' long position.
The idea behind Mineralys Therapeutics, Common and Bright Minds Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets